Original article by Tom Burton
The Australian Financial Review – Page: 9 : 16-Jul-24

CSL has secured a deal to supply 4.8 million vials of its avian influence vaccine to the US. The European Union has in turn agreed to buy 650,000 doses, with an option to buy an additional 40 million shots. Jonathan Anderson from CSL’s Seqirus subsidiary says the zoonotic vaccines can be given to high-risk groups in the US and the EU, such as poultry, dairy and healthcare workers. CSL’s deals come amid growing global concern about the H5N1 bird flu virus, which has spread to every continent except Australia. Three different strains of the less severe H7 strain of bird flu has been detected in Australia.

CORPORATES
CSL LIMITED – ASX CSL, SEQIRUS PTY LTD